Soluble P-selectin, but not circulating cell-free DNA, is a potential diagnostic biomarker in heparin-induced thrombocytopenia
- 17 April 2025
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 23 (7) , 2242-2254
Abstract
No abstract availableKeywords
Funding Information
- Institute for Clinical and Translational Research, University of Wisconsin, Madison (1UM1TR004926-01)
- National Institutes of Health
- National Center for Advancing Translational Sciences
- School of Medicine, Johns Hopkins University
This publication has 44 references indexed in Scilit:
- Total Synthesis of a PSGL-1 Glycopeptide Analogue for Targeted Inhibition of P-SelectinJournal of the American Chemical Society, 2024
- DAMPs and DAMP-sensing receptors in inflammation and diseasesImmunity, 2024
- Plasma Instead of Serum Avoids Critical Confounding of Clinical Metabolomics Studies by PlateletsJournal of Proteome Research, 2024
- Accuracy of Diagnosing Heparin-Induced ThrombocytopeniaJAMA Network Open, 2024
- SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severityeJHaem, 2023
- Association of Thromboxane Generation With Survival in Aspirin Users and NonusersJACC, 2022
- Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infectioneClinicalMedicine, 2021
- Clinical outcomes in a cohort of patients with heparin‐induced thrombocytopeniaAmerican Journal of Hematology, 2017
- Atomic description of the immune complex involved in heparin-induced thrombocytopeniaNature Communications, 2015
- Index for rating diagnostic testsCancer, 1950